Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-19, Stock:ABBV, The news for the past five days is as follows:
2021-05-12: NEWS1: AbbVie to Present at the RBC Capital Markets Global Healthcare Conference.NEWS2: The Zacks Analyst Blog Highlights: Exxon Mobil, AbbVie, Citigroup, Google and Micron.NEWS3: The Best Warren Buffett Stocks to Buy With $300 Right Now.
2021-05-13: NEWS1: Forget Walmart, Here Are 3 Better Dividend Stocks.
2021-05-14: NEWS1: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS2: We Have New Price Targets on Bullish-Looking AbbVie.NEWS3: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.
2021-05-17: nan
2021-05-18: NEWS1: AbbVie Inflated Prices For Two Major Drugs, Engaged In Anticompetitive Practices, House Oversight Report Says.NEWS2: House Committee Takes On Pricing, Patents for Top-Selling Drug Humira.NEWS3: U.S. lawmakers request federal inquiry into AbbVie's actions with drug Humira -statement.NEWS4: AbbVie Slammed in House Report for Pricing Practices. Market Shrugs..NEWS5: UPDATE 3-Lawmakers say AbbVie exploits U.S. patents to protect Humira profits, price hikes.NEWS6: After a Blowout Quarter, Is AbbVie Stock a Buy?.NEWS7: AbbVie exploits U.S. patents to protect profits: Congress report.

Answer: Decrease